Zhaoke Ophthalmology Management
Management criteria checks 3/4
Zhaoke Ophthalmology's CEO is Benjamin Li, appointed in Jan 2017, has a tenure of 7.33 years. total yearly compensation is CN¥21.23M, comprised of 30.6% salary and 69.4% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth HK$261.69K. The average tenure of the management team and the board of directors is 3.4 years and 3.3 years respectively.
Key information
Benjamin Li
Chief executive officer
CN¥21.2m
Total compensation
| CEO salary percentage | 30.6% |
| CEO tenure | 7.3yrs |
| CEO ownership | 0.03% |
| Management average tenure | 3.4yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥385m |
| Sep 30 2023 | n/a | n/a | -CN¥433m |
| Jun 30 2023 | n/a | n/a | -CN¥480m |
| Mar 31 2023 | n/a | n/a | -CN¥444m |
| Dec 31 2022 | CN¥21m | CN¥6m | -CN¥407m |
| Sep 30 2022 | n/a | n/a | -CN¥355m |
| Jun 30 2022 | n/a | n/a | -CN¥303m |
| Mar 31 2022 | n/a | n/a | -CN¥1b |
| Dec 31 2021 | CN¥39m | CN¥6m | -CN¥2b |
| Sep 30 2021 | n/a | n/a | -CN¥2b |
| Jun 30 2021 | n/a | n/a | -CN¥3b |
| Mar 31 2021 | n/a | n/a | -CN¥2b |
| Dec 31 2020 | CN¥3m | n/a | -CN¥727m |
Compensation vs Market: Benjamin's total compensation ($USD2.93M) is above average for companies of similar size in the Hong Kong market ($USD233.89K).
Compensation vs Earnings: Benjamin's compensation has been consistent with company performance over the past year.
CEO
Benjamin Li (60 yo)
7.3yrs
Tenure
CN¥21,225,000
Compensation
Dr. Xiaoyi Li, also known as Benjamin, Ph.D. is Founder of Lee's Pharmaceutical Holdings Limited and serves as its Executive Director & Senior Adviser since April 29, 2021. He serves as the Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 7.3yrs | CN¥21.23m | 0.031% CN¥ 261.7k | |
| Executive Director | 3.6yrs | CN¥2.32m | no data | |
| President & Chief Scientific Officer | 5.1yrs | no data | no data | |
| Chief Business Officer & CFO | 3.4yrs | no data | no data | |
| Group General Counsel | 2.6yrs | no data | no data | |
| Senior Vice President of Corporate Development | 5.3yrs | no data | no data | |
| Senior Vice President of Sales & Marketing | 2.3yrs | no data | no data | |
| Chief Medical Officer | 2.9yrs | no data | no data | |
| Senior Vice President of Manufacturing & Logistics | 2.3yrs | no data | no data | |
| Group Head of Regulatory Affairs | 3.3yrs | no data | no data | |
| VP of Financial Dept. & Company Secretary | 4.7yrs | no data | no data |
3.4yrs
Average Tenure
47yo
Average Age
Experienced Management: 6622's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 7.3yrs | CN¥21.23m | 0.031% CN¥ 261.7k | |
| Executive Director | 3.6yrs | CN¥2.32m | no data | |
| Independent Non-Executive Director | 3.1yrs | CN¥414.00k | no data | |
| Independent Non-Executive Director | 3.1yrs | CN¥414.00k | no data | |
| Non Executive Director | 3.3yrs | CN¥414.00k | no data | |
| Independent Non-Executive Director | 1.9yrs | CN¥302.00k | no data | |
| Non-Executive Director | 7.3yrs | CN¥414.00k | 0.0043% CN¥ 37.0k |
3.3yrs
Average Tenure
60yo
Average Age
Experienced Board: 6622's board of directors are considered experienced (3.3 years average tenure).